Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study To Compare The Efficacy Of Cervical Cytology With Molecular Screening For Detecting Reactive Cellular Changes In The Cervix In An Open Population

NCT07480902 is registered in ClinicalTrials.gov with Timser SAPI de CV as lead sponsor.

NCT NCT07480902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07480902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study To Compare The Efficacy Of Cervical Cytology With Molecular Screening For Detecting Reactive Cellular Changes In The Cervix In An Open Population
Lead sponsor
Timser SAPI de CV
Phase
Not applicable
Overall status
Recruiting
Start date
February 3, 2026
Completion date
June 30, 2026
Enrollment
558 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

i) atypical squamous cells of undetermined significance (asc-us), ii) atypical glandular cells of uncertain significance (agus), iii) cervical intraepithelial neoplasia (cin), cin-1, cin-2, cin-3, iv) low-grade squamous intraepithelial lesion (lsil), v) high-grade squamous intraepithelial lesion (hsil), vi) cervical cancer